Total metadrenaline excretion in patients treated with alpha-methyldopa.

A. Stott,R. Robinson,P. Smith

DOI: https://doi.org/10.1016/S0140-6736(63)90974-7

IF: 202.731

1963-02-02

The Lancet

Abstract:

What problem does this paper attempt to address?

Mitochondrial fatty acid oxidation drives senescence

Shota Yamauchi,Yuki Sugiura,Junji Yamaguchi,Xiangyu Zhou,Satoshi Takenaka,Takeru Odawara,Shunsuke Fukaya,Takao Fujisawa,Isao Naguro,Yasuo Uchiyama,Akiko Takahashi,Hidenori Ichijo

DOI: https://doi.org/10.1126/sciadv.ado5887

IF: 13.6

2024-10-26

Science Advances

Abstract:Cellular senescence is a stress-induced irreversible cell cycle arrest involved in tumor suppression and aging. Many stresses, such as telomere shortening and oncogene activation, induce senescence by damaging nuclear DNA. However, the mechanisms linking DNA damage to senescence remain unclear. Here, we show that DNA damage response (DDR) signaling to mitochondria triggers senescence. A genome-wide small interfering RNA screen implicated the outer mitochondrial transmembrane protein BNIP3 in senescence induction. We found that BNIP3 is phosphorylated by the DDR kinase ataxia telangiectasia mutated (ATM) and contributes to an increase in the number of mitochondrial cristae. Stable isotope labeling metabolomics indicated that the increase in cristae enhances fatty acid oxidation (FAO) to acetyl–coenzyme A (acetyl-CoA). This promotes histone acetylation and expression of the cyclin-dependent kinase inhibitor p16 INK4a . Notably, pharmacological activation of FAO alone induced senescence both in vitro and in vivo. Thus, mitochondrial energy metabolism plays a critical role in senescence induction and is a potential intervention target to control senescence.

multidisciplinary sciences
Re: Kanai A, et al. mechanisms of action of botulinum neurotoxins, β3‐adrenergic receptor agonists, and PDE5 inhibitors in modulating detrusor function in overactive bladders: ICI‐RS 2011. Neurourol urodyn 2012;31:300–308

M. Takeda

DOI: https://doi.org/10.1002/nau.21244

IF: 2.367

2012-06-01

Neurourology and Urodynamics

Abstract:Dear Sir, The beta3-adrenergic receptor agonist, Mirabegron, has just been launched for OAB in Japan in September 2011, and BoNT/A has just been approved for neurogenic overactive bladder by the FDA in August 2011. Tadalafil, a PDE5 inhibitor is now under clinical development for male BPH/LUTS. All three of the drugs act on smooth muscle, resulting in relaxation. However, according to recent findings and the authors’ data, BoNT/A, b3-adrenergic receptor agonists, and PDE5 inhibitors can directly inhibit afferent excitability without decreasing detrusor contractility. These agents may have considerable potential in treating the sensory component of lower urinary tract dysfunction. The authors raise the following problems, which must be resolved as soon as possible:
A criterion for distinguishing level V nodes from clavicular nodes.

J. Butman,P. Lee

2000-06-01

Archives of Otolaryngology - Head and Neck Surgery

Abstract:
Mitochondria are required for pro‐ageing features of the senescent phenotype

Clara Correia-Melo,Francisco D M Marques,Rhys Anderson,Graeme Hewitt,Rachael Hewitt,John Cole,Bernadette M Carroll,Satomi Miwa,Jodie Birch,Alina Merz,Michael D Rushton,Michelle Charles,Diana Jurk,Stephen W G Tait,Rafal Czapiewski,Laura Greaves,Glyn Nelson,Mohammad Bohlooly-Y,Sergio Rodriguez-Cuenca,Antonio Vidal-Puig,Derek Mann,Gabriele Saretzki,Giovanni Quarato,Douglas R Green,Peter D Adams,Thomas von Zglinicki,Viktor I Korolchuk,João F Passos,Clara Correia‐Melo,Francisco DM Marques,Stephen WG Tait,Mohammad Bohlooly‐Y,Sergio Rodriguez‐Cuenca,Antonio Vidal‐Puig,Thomas Zglinicki

DOI: https://doi.org/10.15252/embj.201592862

2016-02-04

The EMBO Journal

Abstract:Cell senescence is an important tumour suppressor mechanism and driver of ageing. Both functions are dependent on the development of the senescent phenotype, which involves an overproduction of pro-inflammatory and pro-oxidant signals. However, the exact mechanisms regulating these phenotypes remain poorly understood. Here, we show the critical role of mitochondria in cellular senescence. In multiple models of senescence, absence of mitochondria reduced a spectrum of senescence effectors and phenotypes while preserving ATP production via enhanced glycolysis. Global transcriptomic analysis by RNA sequencing revealed that a vast number of senescent-associated changes are dependent on mitochondria, particularly the pro-inflammatory phenotype. Mechanistically, we show that the ATM, Akt and mTORC1 phosphorylation cascade integrates signals from the DNA damage response (DDR) towards PGC-1β-dependent mitochondrial biogenesis, contributing to aROS-mediated activation of the DDR and cell cycle arrest. Finally, we demonstrate that the reduction in mitochondrial content in vivo, by either mTORC1 inhibition or PGC-1β deletion, prevents senescence in the ageing mouse liver. Our results suggest that mitochondria are a candidate target for interventions to reduce the deleterious impact of senescence in ageing tissues.
Apoptotic transition of senescent cells accompanied with mitochondrial hyper-function.

Danli Wang,Yang Liu,Rui Zhang,Fen Zhang,Weihao Sui,Li Chen,Ran Zheng,Xiaowen Chen,Feiqiu Wen,Hong-Wei Ouyang,Junfeng Ji

DOI: https://doi.org/10.18632/oncotarget.8536

2016-01-01

Oncotarget

Abstract:Defined as stable cell-cycle arrest, cellular senescence plays an important role in diverse biological processes including tumorigenesis, organismal aging, and embryonic development. Although increasing evidence has documented the metabolic changes in senescent cells, mitochondrial function and its potential contribution to the fate of senescent cells remain largely unknown. Here, using two in vitro models of cellular senescence induced by doxorubicin treatment and prolonged passaging of neonatal human foreskin fibroblasts, we report that senescent cells exhibited high ROS level and augmented glucose metabolic rate concomitant with both morphological and quantitative changes of mitochondria. Furthermore, mitochondrial membrane potential depolarized at late stage of senescent cells which eventually led to apoptosis. Our study reveals that mitochondrial hyper-function contributes to the implementation of cellular senescence and we propose a model in which the mitochondrion acts as the key player in promoting fate-determination in senescent cells.
Spontaneous DNA damage to the nuclear genome promotes senescence, redox imbalance and aging

Andria R Robinson,Matthew J Yousefzadeh,Tania A Rozgaja,Jin Wang,Xuesen Li,Jeremy S Tilstra,Chelsea H Feldman,Siobhán Q Gregg,Caroline H Johnson,Erin M Skoda,Marie-Céline Frantz,Harris Bell-Temin,Hannah Pope-Varsalona,Aditi U Gurkar,Luigi A Nasto,Renã A S Robinson,Heike Fuhrmann-Stroissnigg,Jolanta Czerwinska,Sara J McGowan,Nadiezhda Cantu-Medellin,Jamie B Harris,Salony Maniar,Mark A Ross,Christy E Trussoni,Nicholas F LaRusso,Eugenia Cifuentes-Pagano,Patrick J Pagano,Barbara Tudek,Nam V Vo,Lora H Rigatti,Patricia L Opresko,Donna B Stolz,Simon C Watkins,Christin E Burd,Claudette M St Croix,Gary Siuzdak,Nathan A Yates,Paul D Robbins,Yinsheng Wang,Peter Wipf,Eric E Kelley,Laura J Niedernhofer

DOI: https://doi.org/10.1016/j.redox.2018.04.007

Abstract:Accumulation of senescent cells over time contributes to aging and age-related diseases. However, what drives senescence in vivo is not clear. Here we used a genetic approach to determine if spontaneous nuclear DNA damage is sufficient to initiate senescence in mammals. Ercc1-/∆ mice with reduced expression of ERCC1-XPF endonuclease have impaired capacity to repair the nuclear genome. Ercc1-/∆ mice accumulated spontaneous, oxidative DNA damage more rapidly than wild-type (WT) mice. As a consequence, senescent cells accumulated more rapidly in Ercc1-/∆ mice compared to repair-competent animals. However, the levels of DNA damage and senescent cells in Ercc1-/∆ mice never exceeded that observed in old WT mice. Surprisingly, levels of reactive oxygen species (ROS) were increased in tissues of Ercc1-/∆ mice to an extent identical to naturally-aged WT mice. Increased enzymatic production of ROS and decreased antioxidants contributed to the elevation in oxidative stress in both Ercc1-/∆ and aged WT mice. Chronic treatment of Ercc1-/∆ mice with the mitochondrial-targeted radical scavenger XJB-5-131 attenuated oxidative DNA damage, senescence and age-related pathology. Our findings indicate that nuclear genotoxic stress arises, at least in part, due to mitochondrial-derived ROS, and this spontaneous DNA damage is sufficient to drive increased levels of ROS, cellular senescence, and the consequent age-related physiological decline.
Mitochondrial peptides modulate mitochondrial function during cellular senescence

Su-Jeong Kim,Hemal H Mehta,Junxiang Wan,Chisaka Kuehnemann,Jingcheng Chen,Ji-Fan Hu,Andrew R Hoffman,Pinchas Cohen

DOI: https://doi.org/10.18632/aging.101463

2018-06-10

Abstract:Cellular senescence is a complex cell fate response that is thought to underlie several age-related pathologies. Despite a loss of proliferative potential, senescent cells are metabolically active and produce energy-consuming effectors, including senescence-associated secretory phenotypes (SASPs). Mitochondria play crucial roles in energy production and cellular signaling, but the key features of mitochondrial physiology and particularly of mitochondria-derived peptides (MDPs), remain underexplored in senescence responses. Here, we used primary human fibroblasts made senescent by replicative exhaustion, doxorubicin or hydrogen peroxide treatment, and examined the number of mitochondria and the levels of mitochondrial respiration, mitochondrial DNA methylation and the mitochondria-encoded peptides humanin, MOTS-c, SHLP2 and SHLP6. Senescent cells showed increased numbers of mitochondria and higher levels of mitochondrial respiration, variable changes in mitochondrial DNA methylation, and elevated levels of humanin and MOTS-c. Humanin and MOTS-c administration modestly increased mitochondrial respiration and selected components of the SASP in doxorubicin-induced senescent cells partially via JAK pathway. Targeting metabolism in senescence cells is an important strategy to reduce SASP production for eliminating the deleterious effects of senescence. These results provide insight into the role of MDPs in mitochondrial energetics and the production of SASP components by senescent cells.
Suppressed basal mitophagy drives cellular aging phenotypes that can be reversed by a p62-targeting small molecule

George Kelly,Tetsushi Kataura,Johan Panek,Gailing Ma,Hanna Salmonowicz,Ashley Davis,Hannah Kendall,Charlotte Brookes,Daniel Moscoh Ayine-Tora,Peter Banks,Glyn Nelson,Laura Dobby,Patricia R. Pitrez,Laura Booth,Lydia Costello,Gavin D. Richardson,Penny Lovat,Stefan Przyborski,Lino Ferreira,Laura Greaves,Karolina Szczepanowska,Thomas von Zglinicki,Satomi Miwa,Max Brown,Michael Flagler,John E. Oblong,Charles C. Bascom,Bernadette Carroll,Jóhannes Reynisson,Viktor I. Korolchuk

DOI: https://doi.org/10.1016/j.devcel.2024.04.020

IF: 13.417

2024-06-20

Developmental Cell

Abstract:Summary Selective degradation of damaged mitochondria by autophagy (mitophagy) is proposed to play an important role in cellular homeostasis. However, the molecular mechanisms and the requirement of mitochondrial quality control by mitophagy for cellular physiology are poorly understood. Here, we demonstrated that primary human cells maintain highly active basal mitophagy initiated by mitochondrial superoxide signaling. Mitophagy was found to be mediated by PINK1/Parkin-dependent pathway involving p62 as a selective autophagy receptor (SAR). Importantly, this pathway was suppressed upon the induction of cellular senescence and in naturally aged cells, leading to a robust shutdown of mitophagy. Inhibition of mitophagy in proliferating cells was sufficient to trigger the senescence program, while reactivation of mitophagy was necessary for the anti-senescence effects of NAD precursors or rapamycin. Furthermore, reactivation of mitophagy by a p62-targeting small molecule rescued markers of cellular aging, which establishes mitochondrial quality control as a promising target for anti-aging interventions.

cell biology,developmental biology
Branched-chain amino acid metabolism is a crucial modulator of cellular senescence

Yuma Aramaki,Kazuki Irie,Hideru Obinata,Shinya Honda,Takuro Horii,Satoko Arakawa,Aiko Tsuchida,Junki Hoshino,Ryosuke Kobayashi,Takashi Izumi,Izuho Hatada,Shigeomi Shimizu,Yoji A. Minamishima,Akimitsu Konishi

DOI: https://doi.org/10.1101/2024.09.10.612139

2024-09-10

Abstract:Cellular senescence is a complex stress response that results in the permanent arrest of cell proliferation. The accumulation of senescent cells occurs during aging in living organisms, and contributes to tissue dysfunction. Although there are growing lines of evidence that various metabolic changes occur in senescent cells, the link between cellular metabolism and senescence is not yet fully understood. In this study, we demonstrate that alterations in the metabolism of branched-chain amino acids (BCAAs) play a crucial role in establishing cellular senescence. Furthermore, we identified mitochondrial BCAA transamination as a crucial step in this process. Our findings show that various types of cellular stress lead to a reduction in the expression of BCAA aminotransferase 2 (BCAT2), one of the BCAA catabolic enzymes, resulting in decreased catabolism of BCAAs and reduced synthesis of glutamate. The reduction of BCAA catabolites, together with the consequent limitation in glutathione production from glutamate, triggers cellular senescence. Furthermore, we demonstrate that a reduction in BCAT2 levels alone is sufficient to induce cellular senescence, both in cultured cells and in mice. Additionally, our results demonstrate that aging alters BCAA metabolism in both mice and humans. Our findings provide new insights into the metabolic mechanisms underlying cellular senescence, with a particular focus on the role of BCAAs.

Cell Biology
Autophagy impairment with lysosomal and mitochondrial dysfunction is an important characteristic of oxidative stress-induced senescence

Haoran Tai,Zhe Wang,Hui Gong,Xiaojuan Han,Jiao Zhou,Xiaobo Wang,Xiawei Wei,Yi Ding,Ning Huang,Jianqiong Qin,Jie Zhang,Shuang Wang,Fei Gao,Zofia M. Chrzanowska-Lightowlers,Rong Xiang,Hengyi Xiao

DOI: https://doi.org/10.1080/15548627.2016.1247143

IF: 13.391

2016-11-21

Autophagy

Abstract:Macroautophagy/autophagy has profound implications for aging. However, the true features of autophagy in the progression of aging remain to be clarified. In the present study, we explored the status of autophagic flux during the development of cell senescence induced by oxidative stress. In this system, although autophagic structures increased, the degradation of SQSTM1/p62 protein, the yellow puncta of mRFP-GFP-LC3 fluorescence and the activity of lysosomal proteolytic enzymes all decreased in senescent cells, indicating impaired autophagic flux with lysosomal dysfunction. The influence of autophagy activity on senescence development was confirmed by both positive and negative autophagy modulators; and MTOR-dependent autophagy activators, rapamycin and PP242, efficiently suppressed cellular senescence through a mechanism relevant to restoring autophagic flux. By time-phased treatment of cells with the antioxidant N-acetylcysteine (NAC), the mitochondria uncoupler carbonyl cyanide m-chlorophenyl hydrazone (CCCP) and ambroxol, a reagent with the effect of enhancing lysosomal enzyme maturation, we found that mitochondrial dysfunction plays an initiating role, while lysosomal dysfunction is more directly responsible for autophagy impairment and senescence. Interestingly, the effect of rapamycin on autophagy flux is linked to its role in functional revitalization of both mitochondrial and lysosomal functions. Together, this study demonstrates that autophagy impairment is crucial for oxidative stress-induced cell senescence, thus restoring autophagy activity could be a promising way to retard senescence.
Telomeres and Mitochondrial Metabolism: Implications for Cellular Senescence and Age-related Diseases

Xingyu Gao,Xiao Yu,Chang Zhang,Yiming Wang,Yanan Sun,Hui Sun,Haiying Zhang,Yingai Shi,Xu He

DOI: https://doi.org/10.1007/s12015-022-10370-8

2022-04-23

Stem Cell Reviews and Reports

Abstract:Cellular senescence is an irreversible cell arrest process, which is determined by a variety of complicated mechanisms, including telomere attrition, mitochondrial dysfunction, metabolic disorders, loss of protein homeostasis, epigenetic changes, etc. Cellular senescence is causally related to the occurrence and development of age-related disease. The elderly is liable to suffer from disorders such as neurodegenerative diseases, cancer, and diabetes. Therefore, it is increasingly imperative to explore specific countermeasures for the treatment of age-related diseases. Numerous studies on humans and mice emphasize the significance of metabolic imbalance caused by short telomeres and mitochondrial damages in the onset of age-related diseases. Although the experimental data are relatively independent, more and more evidences have shown that there is mutual crosstalk between telomeres and mitochondrial metabolism in the process of cellular senescence. This review systematically discusses the relationship between telomere length, mitochondrial metabolic disorder, as well as their underlying mechanisms for cellular senescence and age-related diseases. Future studies on telomere and mitochondrial metabolism may shed light on potential therapeutic strategies for age-related diseases.Graphical The characteristics of cellular senescence mainly include mitochondrial dysfunction and telomere attrition. Mitochondrial dysfunction will cause mitochondrial metabolic disorders, including decreased ATP production, increased ROS production, as well as enhanced cellular apoptosis. While oxidative stress reaction to produce ROS, leads to DNA damage, and eventually influences telomere length. Under the stimulation of oxidative stress, telomerase catalytic subunit TERT mainly plays an inhibitory role on oxidative stress, reduces the production of ROS and protects telomere function. Concurrently, mitochondrial dysfunction and telomere attrition eventually induce a range of age-related diseases, such as T2DM, osteoporosis, AD, etc. :increase; :reduce;⟝:inhibition.

cell biology,medicine, research & experimental,cell & tissue engineering
Apoptotic stress causes mtDNA release during senescence and drives the SASP

Stella Victorelli,Hanna Salmonowicz,James Chapman,Helene Martini,Maria Grazia Vizioli,Joel S Riley,Catherine Cloix,Ella Hall-Younger,Jair Machado Espindola-Netto,Diana Jurk,Anthony B Lagnado,Lilian Sales Gomez,Joshua N Farr,Dominik Saul,Rebecca Reed,George Kelly,Madeline Eppard,Laura C Greaves,Zhixun Dou,Nicholas Pirius,Karolina Szczepanowska,Rebecca A Porritt,Huijie Huang,Timothy Y Huang,Derek A Mann,Claudio Akio Masuda,Sundeep Khosla,Haiming Dai,Scott H Kaufmann,Emmanouil Zacharioudakis,Evripidis Gavathiotis,Nathan K LeBrasseur,Xue Lei,Alva G Sainz,Viktor I Korolchuk,Peter D Adams,Gerald S Shadel,Stephen W G Tait,João F Passos

DOI: https://doi.org/10.1038/s41586-023-06621-4

IF: 64.8

Nature

Abstract:Senescent cells drive age-related tissue dysfunction partially through the induction of a chronic senescence-associated secretory phenotype (SASP)1. Mitochondria are major regulators of the SASP; however, the underlying mechanisms have not been elucidated2. Mitochondria are often essential for apoptosis, a cell fate distinct from cellular senescence. During apoptosis, widespread mitochondrial outer membrane permeabilization (MOMP) commits a cell to die3. Here we find that MOMP occurring in a subset of mitochondria is a feature of cellular senescence. This process, called minority MOMP (miMOMP), requires BAX and BAK macropores enabling the release of mitochondrial DNA (mtDNA) into the cytosol. Cytosolic mtDNA in turn activates the cGAS-STING pathway, a major regulator of the SASP. We find that inhibition of MOMP in vivo decreases inflammatory markers and improves healthspan in aged mice. Our results reveal that apoptosis and senescence are regulated by similar mitochondria-dependent mechanisms and that sublethal mitochondrial apoptotic stress is a major driver of the SASP. We provide proof-of-concept that inhibition of miMOMP-induced inflammation may be a therapeutic route to improve healthspan.
Persistent mTORC1 signaling in cell senescence results from defects in amino acid and growth factor sensing

Bernadette Carroll,Glyn Nelson,Yoana Rabanal-Ruiz,Olena Kucheryavenko,Natasha A. Dunhill-Turner,Charlotte C. Chesterman,Qabil Zahari,Tong Zhang,Sarah E. Conduit,Christina A. Mitchell,Oliver D.K. Maddocks,Penny Lovat,Thomas von Zglinicki,Viktor I. Korolchuk

DOI: https://doi.org/10.1083/jcb.201610113

2017-05-31

Abstract:Mammalian target of rapamycin complex 1 (mTORC1) and cell senescence are intimately linked to each other and to organismal aging. Inhibition of mTORC1 is the best-known intervention to extend lifespan, and recent evidence suggests that clearance of senescent cells can also improve health and lifespan. Enhanced mTORC1 activity drives characteristic phenotypes of senescence, although the underlying mechanisms responsible for increased activity are not well understood. We have identified that in human fibroblasts rendered senescent by stress, replicative exhaustion, or oncogene activation, mTORC1 is constitutively active and resistant to serum and amino acid starvation. This is driven in part by depolarization of senescent cell plasma membrane, which leads to primary cilia defects and a resultant failure to inhibit growth factor signaling. Further, increased autophagy and high levels of intracellular amino acids may act to support mTORC1 activity in starvation conditions. Interventions to correct these phenotypes restore sensitivity to the mTORC1 signaling pathway and cause death, indicating that persistent signaling supports senescent cell survival.

cell biology
Mitochondria Damage Checkpoint, Aging, and Cancer

Keshav K Singh,K. K. SINGH

DOI: https://doi.org/10.1196/annals.1354.022

IF: 6.499

2006-05-01

Annals of the New York Academy of Sciences

Abstract:There is growing evidence supporting the progressing decline in mitochondrial function with age. Mitochondria are the major site of reactive oxygen species (ROS) production in the cell; therefore it is likely that progressive decline in mitochondrial function is due to the accumulation of oxidative damage with age. Despite this notion, a role for mitochondria in cellular senescence has been largely ignored. Our studies using mitochondrial gene knockout cells (rho(0)) from a variety of tissue types demonstrate that loss of mitochondrial function leads to cell cycle arrest, cellular senescence, and tumorigenic phenotype. In light of these and earlier studies we hypothesize the existence of a mitochondria damage checkpoint (mitocheckpoint) in human cells. Mitocheckpoint permits cells to arrest in the cell cycle in order to repair/restore mitochondrial function to the normal level. Upon overwhelming, persistent, or severe damage to mitochondria, mitocheckpoint machinery may allow cells to undergo senescence. Thus cellular senescence may function as another checkpoint before cells decide to initiate programmed cell death resulting in aging of tissues and organs. Alternatively, mutations occur in the mitochondrial and/or nuclear DNA, resulting in tumorigenesis.

multidisciplinary sciences
Mitochondrial Dysfunction Increases Oxidative Stress and Decreases Chronological Life Span in Fission Yeast

Alice Zuin,Natalia Gabrielli,Isabel A. Calvo,Sarela García-Santamarina,Kwang-Lae Hoe,Dong Uk Kim,Han-Oh Park,Jacqueline Hayles,José Ayté,Elena Hidalgo

DOI: https://doi.org/10.1371/journal.pone.0002842

IF: 3.7

2008-07-30

PLoS ONE

Abstract:BACKGROUND: Oxidative stress is a probable cause of aging and associated diseases. Reactive oxygen species (ROS) originate mainly from endogenous sources, namely the mitochondria.METHODOLOGY/PRINCIPAL FINDINGS: We analyzed the effect of aerobic metabolism on oxidative damage in Schizosaccharomyces pombe by global mapping of those genes that are required for growth on both respiratory-proficient media and hydrogen-peroxide-containing fermentable media. Out of a collection of approximately 2700 haploid yeast deletion mutants, 51 were sensitive to both conditions and 19 of these were related to mitochondrial function. Twelve deletion mutants lacked components of the electron transport chain. The growth defects of these mutants can be alleviated by the addition of antioxidants, which points to intrinsic oxidative stress as the origin of the phenotypes observed. These respiration-deficient mutants display elevated steady-state levels of ROS, probably due to enhanced electron leakage from their defective transport chains, which compromises the viability of chronologically-aged cells.CONCLUSION/SIGNIFICANCE: Individual mitochondrial dysfunctions have often been described as the cause of diseases or aging, and our global characterization emphasizes the primacy of oxidative stress in the etiology of such processes.

multidisciplinary sciences
Unlocking Mitochondrial Dysfunction-Associated Senescence (MiDAS) with NAD -- a Boolean Model of Mitochondrial Dynamics and Cell Cycle Control

Herbert Joseph Housel Sizek,David Deritei,Katherine Fleig,Marlayna Harris,Peter Lawrence Regan,Kimberly Glass,Erzsebet Ravasz Regan

DOI: https://doi.org/10.1101/2023.12.18.572194

2024-05-14

Abstract:The steady accumulation of senescent cells with aging creates tissue environments that aid cancer evolution. Aging cell states are highly heterogeneous. 'Deep senescent' cells rely on healthy mitochondria to fuel a strong proinflammatory secretome, including cytokines, growth and transforming signals. Yet, the physiological triggers of senescence such as the reactive oxygen species (ROS) can also trigger mitochondrial dysfunction, and sufficient energy deficit to alter their secretome and cause chronic oxidative stress - a state termed Mitochondrial Dysfunction-Associated Senescence (MiDAS). Here, we offer a mechanistic hypothesis for the molecular processes leading to MiDAS, along with testable predictions. To do this we have built a Boolean regulatory network model that qualitatively captures key aspects of mitochondrial dynamics during cell cycle progression (hyper-fusion at the G1/S boundary, fission in mitosis), apoptosis (fission and dysfunction) and glucose starvation (reversible hyper-fusion), as well as MiDAS in response to SIRT3 knockdown or oxidative stress. Our model reaffirms the protective role of NAD+ and external pyruvate. We offer testable predictions about the growth factor- and glucose-dependence of MiDAS and its reversibility at different stages of reactive oxygen species (ROS)-induced senescence. Our model provides mechanistic insights into the distinct stages of DNA-damage induced senescence, the relationship between senescence and epithelial-to-mesenchymal transition in cancer and offers a foundation for building multiscale models of tissue aging.

Systems Biology
Mitochondrial Quality Control Processes at the Crossroads of Cell Death and Survival: Mechanisms and Signaling Pathways

Emanuele Marzetti,Riccardo Calvani,Francesco Landi,Helio José Coelho-Júnior,Anna Picca

DOI: https://doi.org/10.3390/ijms25137305

2024-07-03

Abstract:Biological aging results from an accumulation of damage in the face of reduced resilience. One major driver of aging is cell senescence, a state in which cells remain viable but lose their proliferative capacity, undergo metabolic alterations, and become resistant to apoptosis. This is accompanied by complex cellular changes that enable the development of a senescence-associated secretory phenotype (SASP). Mitochondria, organelles involved in energy provision and activities essential for regulating cell survival and death, are negatively impacted by aging. The age-associated decline in mitochondrial function is also accompanied by the development of chronic low-grade sterile inflammation. The latter shares some features and mediators with the SASP. Indeed, the unloading of damage-associated molecular patterns (DAMPs) at the extracellular level can trigger sterile inflammatory responses and mitochondria can contribute to the generation of DAMPs with pro-inflammatory properties. The extrusion of mitochondrial DNA (mtDNA) via mitochondrial outer membrane permeabilization under an apoptotic stress triggers senescence programs. Additional pathways can contribute to sterile inflammation. For instance, pyroptosis is a caspase-dependent inducer of systemic inflammation, which is also elicited by mtDNA release and contributes to aging. Herein, we overview the molecular mechanisms that may link mitochondrial dyshomeostasis, pyroptosis, sterile inflammation, and senescence and discuss how these contribute to aging and could be exploited as molecular targets for alleviating the cell damage burden and achieving healthy longevity.
[Continuous evaluation of subjective problems in knee joints during balneotherapy of gonarthoses].

J. Ježek

1977-02-01

Abstract:
Fumarate induces redox-dependent senescence by modifying glutathione metabolism

Liang Zheng,Simone Cardaci,Livnat Jerby,Elaine D. MacKenzie,Marco Sciacovelli,T. Isaac Johnson,Edoardo Gaude,Ayala King,Joshua D. G. Leach,RuAngelie Edrada-Ebel,Ann Hedley,Nicholas A. Morrice,Gabriela Kalna,Karen Blyth,Eytan Ruppin,Christian Frezza,Eyal Gottlieb

DOI: https://doi.org/10.1038/ncomms7001

IF: 16.6

2015-01-23

Nature Communications

Abstract:Mutations in the tricarboxylic acid (TCA) cycle enzyme fumarate hydratase (FH) are associated with a highly malignant form of renal cancer. We combined analytical chemistry and metabolic computational modelling to investigate the metabolic implications of FH loss in immortalized and primary mouse kidney cells. Here, we show that the accumulation of fumarate caused by the inactivation of FH leads to oxidative stress that is mediated by the formation of succinicGSH, a covalent adduct between fumarate and glutathione. Chronic succination of GSH, caused by the loss of FH, or by exogenous fumarate, leads to persistent oxidative stress and cellular senescence in vitro and in vivo. Importantly, the ablation of p21, a key mediator of senescence, in Fh1-deficient mice resulted in the transformation of benign renal cysts into a hyperplastic lesion, suggesting that fumarate-induced senescence needs to be bypassed for the initiation of renal cancers.

multidisciplinary sciences
Senescent Cell Depletion Through Targeting BCL-Family Proteins and Mitochondria

Ying Fan,Jiaoqi Cheng,Huihong Zeng,Lijian Shao

DOI: https://doi.org/10.3389/fphys.2020.593630

IF: 4

2020-12-01

Frontiers in Physiology

Abstract:Senescent cells with replicative arrest can be generated during genotoxic, oxidative, and oncogenic stress. Long-term retention of senescent cells in the body, which is attributed to highly expressed BCL-family proteins, chronically damages tissues mainly through a senescence-associated secretory phenotype (SASP). It has been documented that accumulation of senescent cells contributes to chronic diseases and aging-related diseases. Despite the fact that no unique marker is available to identify senescent cells, increased p16 INK4a expression has long been used as an in vitro and in vivo marker of senescent cells. We reviewed five existing p16 INK4a reporter mouse models to detect, isolate, and deplete senescent cells. Senescent cells express high levels of anti-apoptotic and pro-apoptotic genes compared to normal cells. Thus, disrupting the balance between anti-apoptotic and pro-apoptotic gene expression, such as ABT-263 and ABT-737, can activate the apoptotic signaling pathway and remove senescent cells. Mitochondrial abnormalities in senescent cells were also discussed, for example mitochondrial DNA mutation accumulation, dysfunctional mitophagy, and mitochondrial unfolded protein response (mtUPR). The mitochondrial-targeted tamoxifen, MitoTam, can efficiently remove senescent cells due to its inhibition of respiratory complex I and low expression of adenine nucleotide translocase-2 (ANT2) in senescent cells. Therefore, senescent cells can be removed by various strategies, which delays chronic and aging-related diseases and enhances lifespan and healthy conditions in the body.

physiology

Total metadrenaline excretion in patients treated with alpha-methyldopa.

Mitochondrial fatty acid oxidation drives senescence

Re: Kanai A, et al. mechanisms of action of botulinum neurotoxins, β3‐adrenergic receptor agonists, and PDE5 inhibitors in modulating detrusor function in overactive bladders: ICI‐RS 2011. Neurourol urodyn 2012;31:300–308

A criterion for distinguishing level V nodes from clavicular nodes.

Mitochondria are required for pro‐ageing features of the senescent phenotype

Apoptotic transition of senescent cells accompanied with mitochondrial hyper-function.

Spontaneous DNA damage to the nuclear genome promotes senescence, redox imbalance and aging

Mitochondrial peptides modulate mitochondrial function during cellular senescence

Suppressed basal mitophagy drives cellular aging phenotypes that can be reversed by a p62-targeting small molecule

Branched-chain amino acid metabolism is a crucial modulator of cellular senescence

Autophagy impairment with lysosomal and mitochondrial dysfunction is an important characteristic of oxidative stress-induced senescence

Telomeres and Mitochondrial Metabolism: Implications for Cellular Senescence and Age-related Diseases

Apoptotic stress causes mtDNA release during senescence and drives the SASP

Persistent mTORC1 signaling in cell senescence results from defects in amino acid and growth factor sensing

Mitochondria Damage Checkpoint, Aging, and Cancer

Mitochondrial Dysfunction Increases Oxidative Stress and Decreases Chronological Life Span in Fission Yeast

Unlocking Mitochondrial Dysfunction-Associated Senescence (MiDAS) with NAD -- a Boolean Model of Mitochondrial Dynamics and Cell Cycle Control

Mitochondrial Quality Control Processes at the Crossroads of Cell Death and Survival: Mechanisms and Signaling Pathways

[Continuous evaluation of subjective problems in knee joints during balneotherapy of gonarthoses].

Fumarate induces redox-dependent senescence by modifying glutathione metabolism

Senescent Cell Depletion Through Targeting BCL-Family Proteins and Mitochondria